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Chloride/formate exchanger (CFEX; SLC26A6) mediates oxalate transport in various mammalian organs. Studies in Cfex 
knockout mice indicated its possible role in development of male-dominant hyperoxaluria and oxalate urolithiasis. Rats 
provide an important model for studying this pathophysiological condition, but data on Cfex (rCfex) localisation and 
regulation in their organs are limited. Here we applied the RT-PCR and immunochemical methods to investigate rCfex 
mRNA and protein expression and regulation by sex hormones in the pancreas, small intestine, liver, and kidneys from 
intact prepubertal and adult as well as gonadectomised adult rats treated with sex hormones. rCfex cDNA-transfected 
HEK293 cells were used to confirm the specificity of the commercial anti-CFEX antibody. Various biochemical parameters 
were measured in 24-h urine collected in metabolic cages. rCfex mRNA and related protein expression varied in all tested 
organs. Sex-independent expression of the rCfex protein was detected in pancreatic intercalated ducts (apical domain), 
small intestinal enterocytes (brush-border membrane; duodenum > jejunum > ileum), and hepatocytes (canalicular 
membrane). In kidneys, the rCfex protein was immunolocalised to the proximal tubule brush-border with segment-specific 
pattern (S1=S2<S3), and both rCfex mRNA and protein expression exhibited male-dominant sex differences driven by 
stimulatory effects of androgens after puberty. However, urinary oxalate excretion was unrelated to renal rCfex protein 
expression. While the effect of male-dominant expression of rCfex in renal proximal tubules on urine oxalate excretion 
remains unknown, its expression in the hepatocyte canalicular membrane may be a pathway of oxalate elimination via 
bile.
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Chloride/formate exchanger (CFEX), alias putative 
anion transporter 1 (PAT-1), is the 6th member of the SLC26 
transporter family (SLC26A6 in humans, Slc26a6 in 
rodents) and is located in the plasma membrane of various 
cells, where it operates as an exchanger of chloride, 
bicarbonate, oxalate, formate, sulphate, and hydroxyl ions, 
involving pairs of these anions (1-4). In several human and 
animal organs (pancreas, gastrointestinal tract, kidneys) the 
transporter largely mediates Cl-/HCO3
- and/or Cl-/oxalate 
exchange, thus contributing to Cl- (re)absorption and HCO3
- 
or oxalate secretion (4-11).
Studies in human organs have revealed abundant 
expression of CFEX mRNA in the kidneys and pancreas, 
less abundant in the placenta, skeletal muscle, small 
Correspondence to: Ivan Sabolić, MD, PhD, Molecular Toxicology Unit, 
Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 
10000 Zagreb, Croatia, E-mail: sabolic@imi.hr
intestine, heart, and liver, and very low in the lungs, brain, 
and ovaries (12-15). In mice, mCfex mRNA was detected 
in the heart, stomach, small intestine, liver, kidneys, and 
skeletal muscle and less in the brain, lungs, colon, and testes 
(16-18). In rats, rCfex mRNA was detected in the uterus 
(19) and kidneys (10), the pattern in kidneys being cortex 
> outer medulla > inner medulla. However, tissue 
localisation of the CFEX/Cfex protein is controversial. In 
the human pancreas, the protein was immunolocalised to 
the apical surface of duct cells (13), which supports its 
proposed role as a luminal Cl-/HCO3
- exchanger in 
pancreatic ducts (4, 8, 9, 20, 21). In human kidneys the 
transporter was detected in the distal segments of proximal 
tubules and in several more distal nephron segments (12). 
In another study, the protein was immunolocalised to both 
apical and basolateral surfaces of non-specified renal 
tubules (13), which is at odds with the findings in rodent 
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kidneys. In mice, the mCfex protein was localised to the 
brush-border membrane (BBM) of cortical proximal tubules 
(11, 16), apical membrane of villous and crypt cells in 
duodenum (18), glandular cells in the stomach (22), and 
the membranes of atrial and ventricular myocytes in the 
heart (23, 24). These localisations are in accordance with 
mCfex-mediated anion exchange demonstrated in 
functional studies (5–7, 18, 22–29). In rats, the functional 
rCfex protein was demonstrated in microperfusion 
experiments, and immunolocalised to the proximal tubule 
BBM (10).
Most characteristics of this transporter have been 
obtained from studying orthologues in human and mouse 
organs; much less is known about other species, including 
rats [reviewed in (1)]. Human CFEX (759 amino acid 
residues) has been described as a variably glycosylated 
protein with an apparent Mr ranging from ~84 kDa to 
~200 kDa (14, 15, 30). The mouse protein (mCfex; 758 
amino acid residues; Mr ~83 kDa) is 79 % homologous 
with the human (16). In various mCfex-transfected cell lines 
and in mouse organs (pancreas, intestine, kidneys, and heart) 
the Mr of mCfex protein ranges between ~80 kDa and 
~120 kDa (5, 16, 18, 23, 29–32). One study reported Mr of 
~90 kDa for a rat Cfex protein (rCfex; 758 amino acid 
residues; Mr~83 kDa) in isolated renal BBM (10).
Based on the studies in knockout mice, two oxalate 
transporters, sulphate anion transporter 1 (Sat-1/Slc26a1) 
and Cfex have been proposed to play a role in the 
development of hyperoxalaemia, hyperoxaluria, and oxalate 
urolithiasis, a disease which in men occurs 2-3 times more 
often than in women (2, 25, 33–36). Possible contribution 
of Sat-1 in generating male-dominant hyperoxaluria and 
nephrolithiasis was further suggested by a finding of strong, 
androgen hormone-driven sex differences (males > females) 
in the expression of Sat-1 protein and associated oxalate 
transport in the hepatocyte sinusoidal membrane (liver 
being the major oxalate-producing organ) and renal 
proximal tubule basolateral membrane (kidney being the 
oxalate-secreting organ) (37). However, later studies in 
mice (38) and rats (39, 40) could not confirm a significant 
contribution of hepatic and renal Sat-1 in this male-
dominant pathophysiological condition. Other studies using 
mCfex knockout mice have shown that the Cfex transporter 
has a major constitutive role in oxalate secretion across the 
small intestine, which limits the existing paracellular net 
intestinal absorption of dietary oxalate (25, 28, 32). Apart 
from exhibiting a greatly reduced secretory flux, which led 
to hyperoxalaemia and hyperoxaluria, Cfex-deficient mice 
exhibited strong sex-related oxalate urolithiasis, with 3-4 
times higher prevalence in males than in females (25, 34). 
However, the cause of this phenomenon has not been 
identified. We do not know if there are sex differences in 
CFEX/Cfex mRNA and/or protein expression in major 
oxalate-handling organs (intestine, liver, and kidneys) of 
adult humans and animals and if these sex differences affect 
the oxalate secretory function of these organs in health and 
disease. In view of these unknowns, the present study was 
performed in rats, aiming to: a) detect rCfex mRNA 
expression in pancreas, gastrointestinal tract, kidneys, and 
liver, b) immunolocalise in detail the rCfex protein in these 
organs using an antibody with tested specificity, c) detect 
possible sex-related differences in the expression of rCfex 
in these organs at mRNA and protein levels, and d) to link 
the renal expression of rCfex with urine excretion of oxalate 
in male and female rats.
MATERIALS AND METHODS
Animals
In this study, we used prepubertal (three weeks old; 
N=4) and adult (12-13 weeks old; N=3–10 per experimental 
group) male and female Wistar rats bred at the Institute of 
Medical Research and Occupational Health (IMROH) in 
Zagreb, Croatia. The animals were handled in accordance 
with the Directive 2010/63/EU on the protection of animals 
used for scientific purposes and their use was approved by 
the Ethics Committee of IMROH [Approval No. 100-21/14-
7 of 11-06-2014] and by the Ministry of Agriculture, Zagreb 
[Approval No. 525-10/0255-15-4 of 08-09-2015]. Before 
and during experiments, the animals received standard 
pelleted food (4RF21, Mucedola, Italy) and had free access 
to tap water.
Gonadectomy and sex hormone treatment
Prepubertal rats were not treated and were sacrificed at 
three weeks of age. Adult rats were either untreated, sham-
operated, or gonadectomised and were sacrificed at 12-13 
weeks of age. Gonadectomy was performed on six-week 
old males by the scrotal route (castration) and females 
(ovariectomy) by the dorsal (lumbal) approach under 
general intraperitoneal anaesthesia (ketamine hydrochloride, 
80 mg kg-1 bm + xylazine hydrochloride, 12 mg kg-1 bm). 
Sham-operated animals underwent the same procedure, but 
without removing gonads. Gonadectomised and sham-
operated rats were left to recover for six to seven weeks 
before sacrifice. Four castrated animals in each treated 
group received subcutaneous injections of either sunflower 
oil (vehicle) or sex hormones (testosterone enanthate, 
oestradiol dipropionate, or progesterone; each (2.5 mg kg-1 
bm per day for 14 days) dissolved in the vehicle. Four 
control animals received an equivalent amount of oil 
[0.5 mL kg-1 bm per day for 14 days].
Sacrificed animals were harvested for kidneys, liver, 
pancreas, and various intestinal segments (duodenum, 
jejunum, ileum, cecum, and colon), which were then used 
for reverse transcription polymerase chain reaction (RT-
PCR) and immunochemical studies as described below.
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Determination of urine parameters
Three days before sacrifice, each rat was placed in its 
own metabolic cage with free access to water but without 
food. Over the next 24 h their urine was collected and its 
volume measured together with their body mass. Urine was 
centrifuged at 2,500 g for 15 min to remove debris, and 
creatinine, osmolality, citrate, calcium, and oxalate were 
determined in the supernatant as described elsewhere (40).
Antibodies
An affinity purified goat polyclonal antibody for 
C-terminal peptide of the human CFEX [CFEX-Ab, #sc-
26728 (C-17)] with possible cross-reactivity to rat and 
mouse Cfex proteins, the related immunising peptide (#sc-
26728 P), and monoclonal antibody against Na+/K+-ATPase 
α1-subunit (Na+/K+-ATPase-Ab, #sc-48345) were 
purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, 
CA, USA). Monoclonal pan-actin antibody (actin-Ab) was 
purchased from Millipore (Tamecula, CA, USA, 
#MAB1501R). The mouse monoclonal 6xHis antibody 
(6xHis-Ab) was purchased from Clontech Labs/TakaRa 
Bio USA, Inc. (Mountain View, CA, USA, #631212). 
Secondary antibodies were purchased from Jackson 
ImmunoResearch (West Grove, PA, USA) or Kirkegaard 
and Perry (Gaithersburg, MD, USA) and included the CY3-
labelled donkey anti-goat IgG (DAG-CY3), FITC-labelled 
goat anti-mouse IgG (GAM-FITC), and alkaline 
phosphatase-labelled rabbit anti-goat (RAG-AP) and goat 
anti-mouse IgG (GAM-AP).
Chemicals and other material
Anaesthetics ketamine hydrochloride and xylazine 
hydrochloride (Narketan and Xylapan, respectively) were 
purchased from Chassot (Bern, Switzerland), sunflower oil 
solutions of testosterone enanthate, oestradiol dipropionate, 
and progesterone from RotexMedica (Trittau, Germany) 
and Galenika (Belgrade, Serbia), the Immobilon membrane 
from Millipore (Bedford, MA, USA), the markers of protein 
molecular mass from Fermentas Int. (Ontario, Canada), and 
Superfrost® Plus microscope slides from Thermo Scientific 
(Braunschweig, Germany). Other chemicals and reagents 
used in this study were of analytical grade and purchased 
from Sigma (St. Louis, MO, USA) or Fisher Scientific 
(Pittsburgh, PA, USA).
RNA isolation, cDNA synthesis, end-point and real-time 
RT-PCR
The abdomen of anaesthetised rats was opened, their 
large blood vessels cut and exsanguinated under a stream 
of cold water, organs removed, shortly blotted on a filter 
paper, and ~1 mm thick tissue slices of each kidney (middle 
transversal slice), liver, pancreas, and intestinal segments 
(duodenum, jejunum, ileum, cecum, and colon) cut off, and 
immediately immersed in a RNAlater solution (Sigma, St. 
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Louis, MO, USA). Total RNA from these tissues was 
extracted using Trizol (Invitrogen, Karlsruhe, Germany) 
and subsequently purified using the RNeasy Mini Kit 
(Qiagen, Venlo, The Netherlands) respecting the 
manufacturer’s instructions. RNA concentration and purity 
were estimated spectrophotometrically (BioSpec Nano, 
Shimadzu, Japan), and the integrity of RNAs was verified 
under ultraviolet light after agarose gel electrophoresis and 
ethidium bromide staining. Isolated RNA was stored at 
-70 °C until further use. First strand cDNA synthesis was 
performed using the High-Capacity cDNA RT Kit (Applied 
Biosystems, Foster City, CA, USA) following the 
manufacturer’s instructions. cDNA was stored at -20 °C 
until further use.
The end-point PCR was performed on a 25 µL total 
volume sample with 100 ng of the first-strand cDNA 
template, 0.4 µmol L-1 of specific primers, 0.2 mmol L-1 of 
dNTP mixture (Applied Biosystems, USA), 1x AmpliTaq® 
DNA polymerase buffer (Applied Biosystems), 0.025 U µL-1 
of AmpliTaq® DNA polymerase (Applied Biosystems), and 
14.9 µL nuclease-free water. The primers for rCfex, rβ-
actin, and rHprt1 genes were custom-designed with a 
Primer 3 freeware (41, 42), and synthesised and purchased 
from Invitrogen (Carlsbad, California, USA). Intron over-
spanning primers were used to avoid amplification of 
genomic DNA. The exact sequence of these primers and 
their predicted size are listed in Table 1.
Reaction conditions during PCR were as follows: initial 
DNA denaturation at 94 °C for 3 min, DNA denaturation 
at 95 °C for 30 sec, annealing at 57 °C for 30 sec, and 
elongation at 72 °C for 45 sec. PCR products were separated 
with electrophoresis in 1.5 % agarose gel stained with 
ethidium bromide and visualised under ultraviolet light. 
Non-template control reactions, where cDNA was 
substituted with nuclease-free water, did not result in 
detectable products indicating contamination-free PCR 
reactions (data not shown). cDNA input variations were 
controlled in different tissues with two housekeeping genes 
(rβ-actin and rHprt1). The number of PCR cycles within 
the exponential phase of the PCR reaction was 30 cycles 
for rCfex in the kidney, liver, and pancreas, 23 cycles for 
rCfex in the intestinal segments, 25 cycles for rβ-actin in 
the kidney and liver, 30 cycles for rHprt1 in the pancreas, 
and 27 cycles for rHprt1 in the intestinal segments.
Quantitative real-time RT-PCR (qRT-PCR) of 
independent renal RNA isolated from four intact rats of 
each sex was performed on a 25 µL total volume sample 
with 100 ng of the first-strand cDNA template, 12.5 µL of 
2x TaqMan® Universal PCR Master Mix, and 1.25 µL of 
20x TaqMan® Gene Expression Assays mix (all from 
Applied Biosystems). Primers and probes were designed 
by Applied Biosystems and supplied as a TaqMan® Gene 
Expression Assay mix containing a 20x mix of unlabelled 
PCR forward and reverse primers and a TaqMan® MGB 
probe. Assay IDs for the rat genes were Rn01445892_m1 
(rCfex) and Rn00667869_m1 (rβ-actin). mRNA was 
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quantified with TaqMan® Assays (Applied Biosystems) 
according to the manufacturer’s instructions. Amplification 
and detection were performed using the 7500 RT-PCR 
System (Applied Biosystems). Thermal cycling conditions 
were 50 °C for 2 min and 95 °C for 10 min, followed by 
40 two-step cycles of denaturation (95 °C for 15 sec) and 
annealing/extension (60 °C for 1 min). NTC reactions were 
included in each run to check for possible contamination. 
The housekeeping gene rβ-actin was quantified for 
endogenous control, and the results were normalised to 
these values. mRNA expression was quantified with the 
comparative CT method using the Relative Quantification 
Study Software supplied by Applied Biosystems (43). Each 
reaction was performed in duplicate.
Cloning and expression of rCfex in HEK293 cells
The rCfex gene coding sequence (GeneBank accession 
number NP_001137289.1) was amplified from the 
previously synthesised rat kidney cDNA using forward and 
reverse primer pairs (Table 1) with Phusion High-Fidelity 
DNA polymerase (Finnzymes, Vantaa, Finland). The 
amplicon was cloned into pJET 1.2 vector (ThermoFisher 
Scientific, Waltham, MA, USA) following the previously 
described procedure (44). Recombinant plasmid carrying 
the cloned rCfex sequence was purified from two 
transformed (PCR-screened) competent bacterial DH5α 
cells (clones) (ThermoFisher Scientific) using the plasmid 
isolation kit QIAprep Spin Miniprep Kit (Qiagen). The 
rCfex gene sequence was verified by sequencing of both 
purified plasmids on an ABI PRISM® 3100-Avant Genetic 
analyser with the primers listed in Table 2. Using the 
introduced sites for NheI, EcoRI, and ApaI, and restriction 
enzyme digestion, it was possible to subclone rCfex cDNA 
from the pJET 1.2 multiple cloning site into pcDNA3.1/
HisC (Invitrogen) expression vector with and without the 
polyHis tag (Invitrogen). Both pcDNA vectors were used 
in parallel to transiently transfect HEK293 cells using the 
PEI (polyethyleneimine) reagent method (45). An additional 
HEK293 cell culture was used as negative control, which 
underwent the same transfection procedure, except that the 
plasmid did not contain the rCfex gene sequence (vector-
transfected cells). For immunocytochemical studies the 
cells were seeded 48 h before transfection in coverslip 
24-well plates at cell density of 1.85x105 cells per mL. 
Transfection efficiency was evaluated 24 h after transfection 
on a separate HEK293 cell culture with pcDNA3.1/His/
LacZ plasmid following the LacZ staining protocol (46).
Immunocytochemistry
When transfection efficiency exceeded 70 % (24 h after 
transfection), rCfex-transfected and vector-transfected 
HEK293 cells on coverslips were fixed in 4 % p-formaldehyde 
(PFA) for 30 min, extensively rinsed in PBS, and then stored 
in PBS at 4 °C until further use. Removed tissue pieces 
(kidney, liver, pancreas, duodenum, jejunum, ileum, cecum, 
and colon) were fixed overnight in 4 % PFA, extensively 
rinsed in PBS, and stored in PBS (+0.02 % NaN3) at 4 °C. 
When needed, they were infiltrated with 30 % sucrose (in 
PBS) overnight, frozen at –25 °C, cut into 4-µm thick 
cryosections (cryostat Leica CM 1850, Leica Instruments, 
Nussloch, Germany), and placed on Superfrost® Plus 
microscope slides (Fischer Scientific).
Optimal steps for immunostaining with fixed HEK293 
cells have been described in detail earlier (37, 40) and 
included microwave heating in citrate buffer (pH 6), 
treatment with Triton X-100 containing buffers, incubation 
in primary CFEX-Ab, Na+/K+-ATPase-Ab or 6xHis-Ab 
(each diluted in PBS, 1:100) at 4 °C overnight, rinsing in 
Table 1 Primer sequences used for end-point RT-PCR
Gene Forward (f) / reverse (r) primers (5ꞌ→3ꞌ) Accession No. Gene Bank Location PCR product size (bp)








rHprt1 f:TGCTCGAGATGTCATGAAGG r:AGAGGTCCTTTTCACCAGCA NM_012583.2
213-232 
554-573 361
Table 2 Forward (f) and reverse (r) primer sequences used for rCfex gene cloning and sequencing
Primer position Primer sequence (5ꞌ→3ꞌ) Restriction enzyme sites
f TTAG^CTAGCG^AATTCATGGGACTGCCTGATGGGT NheI, EcoRI
r TTAGGGCC^CTC^TCGAGTCAGAGTTTGGTGGCCAAAAC ApaI, XhoI
f 695 TCAAGTATGTGTTTGGCATCAA /
r 800 TTGCTGTGACCACGGTGC /
f 1400 TCTGGAAGGCAAATCGAGT /
r 1500 GAAGACTATGGAGACTGCC /
The underlined parts of primer sequences were introduced for digestion with specific restriction enzymes
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Triton-X-100 containing buffers, incubation in secondary 
antibodies DAG-CY3 or GAM-FITC at room temperature 
for 1 h, and extensive rinsing in PBS between all 
incubations. In some experiments, CFEX-Ab was pre-
incubated with its immunising peptide (0.5 mg mL-1) at 
room temperature for 4 h before immunocytochemistry. In 
double staining experiments (CFEX-Ab + Na+/K+-ATPase-
Ab), tissue cryosections were first incubated with CFEX-Ab 
overnight, then with DAG-CY3 for 1 h, then with Na+/
K+-ATPase-Ab overnight and GAM-FITC for 1 h, applying 
all other steps as described above. The samples were finally 
overlaid with fluorescence fading retardant Vectashield 
(Vector Laboratories, Burlingame, CA), closed with a 
coverslip, and the resulting immunostaining was examined 
with an Opton III RS fluorescence microscope (Opton 
Feintechnik, Oberkochen, Germany). Images were taken 
with the computer-guided Spot RT slider digital camera and 
software (Diagnostic Instruments, Sterling Heights, MI, 
USA). All images were taken using the identical microscope 
and camera settings and imported into Adobe Photoshop 
6.0 (Adobe Systems, San Jose, CA, USA) for processing, 
assembling, and labelling.
Pixel intensity of CY3 fluorescence was measured in 
the original images with Image-J software, version 1.46r 
(NIH, Bethesda, MD, USA). In one cryosection of each 
organ stained with CFEX-Ab, three to four representative 
images were captured using the 25x magnification objective. 
In each image, six to ten randomly-chosen regions of 
interest (ROI) of the staining-positive membranes were 
encircled. Fluorescence intensity in ROI was measured, 
averaged, and subtracted for background fluorescence 
intensity of non-stained cytoplasm. The average value of 
all measurements in respective cryosections was used as 
one datum in further calculations.
Western blotting
The removed kidneys were decapsulated and used in 
toto, or the tissue was manually dissected into cortex and 
outer stripe and processed further as separate tissue pools. 
The main liver lobe and the pancreas were used in toto. The 
intestinal segments (duodenum, jejunum, ileum, cecum, 
and colon) were separated, and their mucosa scraped and 
processed further. Tissue samples were homogenised, and 
total cell membranes (TCM; pellet between 6,000 g and 
150,000 g) were isolated from each homogenate by 
differential centrifugation, as previously described in detail 
elsewhere (37). Proteins were measured with the Bradford 
assay (47).
For PAGE, isolated TCM were prepared in reducing 
conditions (with 5 % β-mercaptoethanol) at 65 °C for 15 
min, their proteins (80 μg lane-1) separated through 10 % 
SDS-PAGE mini gels, and wet-transferred by electrophoresis 
to an Immobilon membrane (Millipore, Bedford, MA, USA) 
as described in detail elsewhere (37). The Immobilon 
membrane was then incubated in the buffer containing 
CFEX-Ab (1:250) or actin-Ab (1:1000) at 4 °C overnight, 
rinsed, incubated in RAG-AP (1:500) or GAM-AP (1:1000) 
at room temperature for 1 hour, and rinsed again. Protein 
bands were visualised at pH 9 via alkaline phosphatase 
activity-mediated reaction using the BCP/NBT method (37). 
To verify the specificity of CFEX-Ab for its immunising 
peptide, the antibody was pre-incubated with the peptide 
(0.5 mg mL-1) at room temperature for 4 h and used in the 
blotting assay. Labelled protein bands were evaluated by 
densitometry using Image-J software. The broadest protein 
band of rCfex or actin was encircled, an equal area was then 
applied to other related bands on the same membrane, and 
the area density of each band was expressed in arbitrary 
units, relative to the broadest band density (=1 unit).
Statistical analysis
Immunochemical data represent the findings for three 
to four animals from each experimental group. RT-PCR 
was done with cDNA obtained from independent RNA 
preparations from individual organs of three to four animals 
from each experimental group. Data shown as mean±standard 
deviation (SD) were statistically analysed with either 
Student’s t-test or ANOVA/Duncan test at 5 % level of 
significance using Statistica 10 (StatSoft, Tulsa, OK, USA).
RESULTS
Expression of rCfex mRNA in rat organs
Figure 1 shows that the expression of rCfex mRNA 
measured at 30 PCR cycles varied between the pancreatic, 
renal, and liver tissues. In the intestine, its expression was 
segment-dependent. Measured at 23 PCR cycles, the 
expression pattern was as follows: duodenum > jejunum > 
ileum. In the stomach (not shown), cecum, and colon it was 
negligible, and barely increased at 30 PCR cycles (data not 
shown).
Immunochemical characterisation of CFEX-Ab in 
rCfex-transfected HEK293 cells
In preliminary immunocytochemical experiments, we 
have tested the CFEX-Ab in cryosections and paraffin 
sections of human, mouse, and rat kidneys and liver by 
applying different antigen-unmasking techniques (48), and 
found immunoreactivity only in rat organs (data not shown). 
To verify the specificity and efficiency of this antibody in 
detecting the rCfex protein, CFEX-Ab was tested in vector- 
and rCfex-transfected HEK293 cells. Figure 2A shows that 
CFEX-Ab stained the plasma membrane of rCfex-
transfected, but not of vector-transfected cells, whereas Na+/
K+-ATPase-Ab stained the plasma membrane of both kinds 
of transfected cells. In addition, rCfex-transfected cells were 
not stained when we used CFEX-Ab pre-incubated with its 
immunising peptide (Figure 2B). These findings suggest 
that CFEX-Ab is specific for the rCfex protein in 
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immunocytochemical analysis. In order to obtain a visible 
rCfex-related protein band for SDS-PAGE and Western 
blotting, we isolated the plasma membranes from the rCfex-
transfected and vector-transfected cells and incubated them 
with or without reducing agent (5 % β-mercaptoethanol) at 
different temperatures (37 °C for 30 min, 65 °C for 15 min, 
95 °C for 5 min). However, for unknown reason, we 
obtained none (data not shown), as opposed to rat tissues.
Expression of the rCfex protein in pancreas
In the Western blots of the TCM isolated from the 
pancreas of male rats, CFEX-Ab labelled a single protein 
band of ~120 kDa (Figure 3A, -P), which was absent when 
the antibody was blocked with the immunising peptide (+P). 
Similarly, CFEX-Ab stained the luminal domain of acini 
(Fig. 3B, -P, arrowhead) in tissue cryosections, but there 
was no staining when the antibody was blocked with the 
immunising peptide (+P) (Figure 3B). In double staining 
experiments (Figures 3C, X, Y, and W), CFEX-Ab stained 
the luminal domain of acini in red-yellow (arrows), whereas 
Na+/K+-ATPase-Ab stained the cell basolateral membrane 
in green (arrowheads). CFEX-Ab also stained the luminal 
membrane of initial (intercalated) ducts (Y, double 
arrowhead), but not the Langerhans’ islet cells (W, LI) and 
large pancreatic ducts (W, asterisk). Because of the low 
image resolution we could not discern if the luminal staining 
in the acini was present only in the membranes of initial 
(intercalated) ducts or also in the luminal membrane of 
acinar cells. However, numerous discrete red-stained 
organelles inside the acinar cells (Figures 3C, Y, and inset 
in Figure 3F, Male) indicate that rCfex may also be present 
inside the acinar cells. In the Western blots of TCM with 
CFEX-Ab and actin-Ab (Figure 3D) and in the densitometric 
evaluation of the protein bands (Figure 3E) the related band 
density of each protein was similar in both sexes. This result 
was confirmed in tissue cryosections from male and female 
organs, where CFEX-Ab-related immunostaining in 
pancreatic ducts was similar in both sexes (Figure 3F).
Expression of the rCfex protein in intestine
In the Western blots of TCM isolated from duodenal 
mucosa, CFEX-Ab labelled a protein band of ~120 kDa 
(Figure 4A, -P) but the staining was absent when the 
antibody was blocked with the immunising peptide (+P). 
The same was true for the cryosections of the duodenal 
tissue; CFEX-Ab strongly stained the BBM of enterocytes 
(Figure 4B, -P), but the staining was absent when the 
immunising peptide-blocked antibody was used (+P). In 
Western blots of TCM from various intestinal segments, 
CFEX-Ab and actin-Ab labelled the rCfex protein band in 
the membranes from the duodenum and jejunum (duodenum 
> jejunum), but not in ileum, cecum, and colon (Figures 4C 
and D). Accordingly, in tissue cryosections the rCfex protein 
was immunolocalised to the BBM of enterocytes in the 
duodenum and jejunum (duodenum > jejunum) but not in 
the ileum, cecum, and colon (Figures 4E and F). The 
staining intensity in the duodenal villi increased about six 
times towards the tip compared to the basal domain (Figures 
4G and H). The staining distribution and intensity was 
similar between males and females (data not shown).
Segmental, zonal, and sex differences in kidney rCfex 
expression
In Western blots of the TCM from the whole male 
kidneys, CFEX-Ab labelled a single protein band of 
Figure 1 rCfex mRNA expression in rat organs as determined by end-point RT-PCR. Housekeeping genes rHprt1 and β-actin were 
used as loading controls. RNA was isolated from the pancreas, kidneys, and liver of three male rats. For each intestinal segment one 
male rat was used, but representative for similar findings in three animals. D – duodenum; J – jejunum; I – ileum; Ce – cecum; Co 
– colon
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~120 kDa, which was absent when the same antibody was 
pre-incubated with its immunising peptide (Figure 5A). In 
tissue cryosections, the antibody staining was weak in the 
BBM of the S1/S2 cortex segments of the proximal tubules, 
stronger in the S3 segments of medullary rays, and the 
strongest in the S3 segments of the outer stripe (-P) (Figures 
5B and C), exhibiting in this way zonal differences (cortex 
< outer stripe). Other nephron segments remained unstained. 
No staining was observed with the antibody pre-incubated 
with its immunising peptide (Figure 5B, +P).
Zonal differences in immunostaining were confirmed 
in the Western blots of isolated TCM from the kidney cortex 
and outer stripe; the rCfex-related protein band of ~120 kDa 
was stronger in the outer stripe (Figure 5D). Its density was 
7.3 times higher than in the cortex, whereas the density of 
the actin band (where the housekeeping protein was used 
as loading control) was similar in TCM from both zones 
(Figure 5E).
The expression of rCfex in the rat kidneys also exhibited 
sex differences (Figure 6). The relative expression of rCfex 
mRNA in the whole kidney, established with qRT-PCR, 
was ~20 % higher in males than in females (P<0.050) 
(Figure 6A). This observation was confirmed on the protein 
level in TCM isolated from the whole male and female 
kidneys; the rCfex-related protein band (~120 kDa) was 
~50 % stronger in males than in females, whereas the actin 
band had similar density in both sexes (Figure 6B and C). 
Sex-dependent expression of the rCfex protein was also 
confirmed by immunostaining the kidney cryosections 
(Figure 6D); CFEX-Ab-related staining intensity in the 
cortical and outer stripe tubules was ~30 % and ~4.3 times 
stronger in males than in females (Figure 6E).
Renal expression of the rCfex protein in prepubertal rats
Western blotting with CFEX-Ab and actin-Ab of the 
whole kidney TCM from four male and four female 
prepubertal rats showed ~60 % lower rCfex protein band 
density than in the adult male and ~100 % higher than in 
the adult female rats, one of each, that served as comparators. 
However, we found no sex differences. The density of the 
actin protein band was also similar between the sexes, but 
~55 % lower than in adult animals (Figures 7A and B).
Western blotting was confirmed by the CFEX-Ab-
related immunostaining in the kidney cortex and outer stripe 
in adult and prepubertal male and female rats (Figure 7C). 
In adult animals it exhibited male-dominant sex differences 
(stronger staining in the outer stripe), and in prepubertal 
animals the immunostaining in both tissue zones was weak 
and similar between the sexes.
Figure 2 Testing the specificity of anti-CFEX antibody. A Immunocytochemical testing of CFEX-Ab and Na+/K+-ATPase-Ab in vector- 
(-rCfex cDNA) and rCfex-transfected (+rCfex cDNA) HEK293 cells. Arrows denote immunoreactivity in the plasma membrane. 
B Immunostaining of rCfex-transfected cells with CFEX-Ab (-Peptide) and its absence when blocked with the immunising peptide 
(+Peptide). Bar (for all images in the panel), 20 µm. Similar results were obtained in three independent experiments
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Effect of gonadectomy and treatment with sex hormones 
on the rCfex protein expression in kidneys
In male rats, the rCfex protein band density in Western 
blots decreased 60 % after castration, whereas actin band 
density remained unchanged (Figures 8A and B). In tissue 
cryosections, the CFEX-Ab-related immunostaining was 
not significantly affected by castration in the cortical 
tubules, but in the outer stripe tubules staining intensity 
decreased ~65 % (Figures 8C and D). In female animals, 
however, the density of protein bands in the whole kidney 
TCM, and the staining intensity of proximal tubules in tissue 
cryosections remained unchanged after ovariectomy (data 
not shown), which clearly suggests that female sex 
hormones are not responsible for the observed phenomenon.
To confirm male sex hormones as being responsible for 
sex differences in the renal rCfex expression, castrated 
males were treated with sunflower oil or oil-solutions of 
testosterone, oestradiol, or progesterone for two weeks 
(Figure 9). Western blotting with CFEX-Ab (Figure 9A) 
and rCfex-related band densitometry (Figure 9B) showed 
that Cfex protein expression was upregulated by testosterone, 
whereas oestradiol and progesterone treatment had no 
effect. CFEX-Ab-related immunostaining in the cortical 
tubules showed no changes, but in the outer stripe, 
testosterone treatment resulted in stronger staining, while 
oestradiol and progesterone had no effect (Figure 9C).
Urine parameters in sham-operated and gonadectomised 
male and female rats
In order to estimate if the renal expression of Cfex in 
sham-operated and gonadectomised male and female rats 
has any relation to urine excretion of oxalate and a few 
other parameters known to stimulate (calcium; Ca) or inhibit 
(citrate) formation of oxalate stones (2), these parameters 
were determined in urine collected in metabolic cages for 
24 h. Table 3 shows that sham-operated females had a 
significantly lower body mass (P<0.001) and higher urine 
Ca (P<0.001) and citrate excretion per day (P<0.002) than 
sham-operated males, when expressed per creatinine.
Castrated males had lower urine volume excretion 
(P<0.002) and higher urine osmolality (P<0.021), creatinine 
(P<0.012), and Ca (P<0.021) than sham-operated males. 
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Figure 3 Immunolocalisation and sex-independent expression of the rCfex protein in the pancreas. A Western blot of total cell membranes 
(TCM) from the whole male pancreas with CFEX-Ab (-P) and with CFEX-Ab blocked by the immunising peptide (+P). Each lane contained 
80 µg of protein. Mr – relative molecular mass. B Tissue cryosection staining with CFEX-Ab (-P), and with CFEX-Ab blocked by its immunising 
peptide (+P). The arrows point to the staining of the luminal domain in the acini. C (X, Y, W) Double staining with CFEX-Ab (arrows) and 
Na+/K+-ATPase-Ab (arrowheads). Double arrowhead points to the initial (intercalated) duct. LI – Langerhans islet; * – larger (intralobular) 
pancreatic duct. D Western blots of TCM from male and female rat pancreata with CFEX-Ab and actin-Ab. Each lane contained 80 µg of 
protein from membrane preparations from different rats. E Densitometry (means ±SD; n=3 in each bar) of the protein bands shown in D. 
Differences in rCfex or actin between males and females were not significant (P>0.05). F CFEX-Ab immunostaining in cryosections of male 
and female organs. The data represent similar findings in three rats of each sex. Bars (for all images in the respective panel), 20 µm
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Ovariectomised females had higher body mass (P<0.001) 
and creatinine excretion (P<0.030), but lower urine flow 
(P<0.019) and citrate excretion (P=0.002), when expressed 
per creatinine than sham-operated females. However, the 
concentration of oxalate in urine, as well as the daily 
excretion of oxalate were similar in sham-operated animals 
of either sex and were not affected by gonadectomy.
rCfex protein expression in the liver
In the liver of adult rats, the CFEX-Ab-related, 
immunising peptide-blockable immunoreactivity was 
localised in the membrane of bile canaliculi (Figure 10A, 
-P, arrows). This was confirmed by double staining with 
CFEX-Ab and Na+/K+-ATPase-Ab, where the rCfex protein 
was stained red in the bile canaliculi (arrows), while the 
Na+/K+-ATPase α-subunit protein was stained green in the 
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Figure 4 Expression of the rCfex protein in the intestine. A Western blot of total cell membranes (TCM) from duodenal mucosa with 
CFEX-Ab (-P) and with the same antibody preincubated with its immunising peptide (+P). Each lane contained 80 µg protein. Mr, 
relative molecular mass. B Immunostaining in duodenum with CFEX-Ab (-P) and with the antibody preincubated with its immunising 
peptide (+P). C Representative (out of 3 similar) Western blots of TCM from the intestinal segments with CFEX-Ab and actin-Ab. Du, 
duodenum; J, jejunum; I, ileum; Ce, cecum; Co, colon. Each lane contained 80 µg protein. D Densitometric evaluation of the rCfex-
related protein bands shown in B, collected from 3 independent experiments. Shown are means ±SD (n=3 in each bar). *J vs. Du, 
P<0.001. The density of actin band was similar in all segments (Actin in C; density not measured). E Representative (out of 4 similar) 
immunostaining of the rCfex protein in various intestinal segments. F Relative staining intensity in BBM from Du and J. Shown are 
means ±SD (n=4 in each bar). *J vs. Du, P<0.001. G Representative (out of 4 similar) CFEX-Ab-related immunostaining along the 
duodenal villous apical (apex) and basal (base) parts. H Relative staining intensity (means ±SD) in duodenal villi (n=4 in each bar). 
*Base vs. Apex, P<0.001. Bars (for all images in the respective panel), 20 µm
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Figure 5 Immunolocalisation of rCfex in male kidneys; zonal and segmental differences. A Western blot of total cell membranes (TCM) 
from the whole kidney with CFEX-Ab (-P) and with the same antibody preincubated with its immunising peptide (+P). Each lane 
contained 80 µg protein. Mr, relative molecular mass. B and C Zonal and segmental differences in immunostaining with CFEX-Ab 
(-P) and with the same, peptide-blocked antibody (+P). CO, cortex; MR, medullary rays; OS, outer stripe; IS, inner stripe; PAP, papilla 
(inner medulla); G, glomeruli. S1/S2, proximal tubule convoluted segments. S3, proximal tubule straight segment. Bar (for all images 
in the respective panel), 20 µm. Data are representative for similar findings in tissue cryosections from 3 male rats. D Western blots 
of TCM from the kidney cortex and outer stripe with CFEX-Ab and actin-Ab. Actin (~42 kDa protein) was used as a loading control. 
Each lane contained 80 µg protein from different membrane preparation. E Densitometric evaluation of the protein bands shown in 
D. Bars show mean ±SD (n=4 in each group). *vs. rCfex in CO, P<0.001
Figure 6 Sex differences in the expression of rCfex mRNA and protein in the kidneys. A qRT-PCR. Relative expression of rCfex mRNA 
from the whole male and female kidneys. Shown are means ±SD (n=4 in each group; *vs. Males, P<0.05). B Western blots of TCM, 
isolated from the whole male and female kidneys, with CFEX-Ab and actin-Ab. Each lane contained 80 µg protein from different 
membrane preparation. C Densitometric evaluation of the protein bands shown in B. Bars show mean ±SD (n=4 in each group). *vs. 
rCfex in Males, P<0.008). D Representative (for four animals of each sex), CFEX-Ab-related immunostaining in proximal tubules in 
the cortex (CO) and outer stripe (OS) of male and female kidneys. G, glomerulus. S1/S2 and S3, respective proximal tubule segments. 
Bar (for all images), 20 µm. E Intensity of CFEX-Ab-related staining in the proximal tubule brush-border membrane of cortical (CO) 
and outer stripe (OS) segments. Shown are means ±SD (n=4 in each group). Statistics: a vs. c, and b vs. d, P<0.003
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hepatocyte sinusoidal membrane (arrowheads). 
Immunoblotting of TCM isolated from the liver tissue with 
CFEX-Ab labelled a protein band of ~120 kDa, which was 
blocked by the immunising peptide (Figure 10B). 
Furthermore, blots of isolated TCM from male and female 
livers with CFEX-Ab and actin-Ab (Figure 10C) and 
densitometry of their protein bands (Figure 10D) showed 
no sex differences in the abundance. This was supported 
by similar CFEX-Ab-related staining intensity in tissue 
cryosections from both sexes (Figure 10E).
DISCUSSION
In this study we established the expression and 
distribution of rCfex mRNA and the rCfex protein in the 
pancreas, gastrointestinal tract, kidneys, and liver of male 
and female rats. End-point RT-PCR detected rCfex mRNA 
in the tissue of all tested organs, which confirms earlier 
findings in humans (12–15), mice (16–18), and rats (10). 
In our initial immunocytochemical studies in the rCfex-
transfected cells, the CFEX-Ab was found efficient in 
immunostaining the rCfex protein in the cell plasma 
membranes. It also exhibited good efficiency in 
immunostaining rCfex in tissue cryosections, whereas in 
the membranes isolated from the investigated rat organs it 
labelled a single, immunising peptide-blockable protein 
band of ~120 kDa. This size of the Cfex protein falls within 
the range detected in various mammalian tissues and cell 
expression systems (~84 kDa to ~200 kDa) and is attributed 
to variable posttranslational modifications such as 
glycosylation (5, 14–16, 18, 23, 29–32). In various 
experimental conditions, the density of ~120 kDa protein 
band and CFEX-ab-related staining distribution and 
intensity in the respective organs matched, indicating their 
protein-related origin. Sex differences (males > females) 
in the expression of both rCfex mRNA and the protein were 
detected only in the kidneys.
Our finding of the rCfex (PAT-1) protein in the rat 
pancreas confirms previous reports for human and animal 
pancreas (4, 8, 9, 13, 20, 21). Studies on microperfused 
pancreatic ducts and ductal cell lines, suggest that Cfex 
(regulated by CFTR) is the major apical Cl-/HCO3
- 
exchanger in mammalian pancreatic ducts and that it 
contributes to the secretion of HCO3
--rich fluid (4, 6, 21, 
49). However, in contrast to previous immunocytochemical 
and functional findings of Cfex in the luminal membrane 
of interlobular duct cells of human (13), guinea pig (9), and 
mouse (6) pancreas, our study demonstrated: a) no CFEX-
Ab-related immunoreactivity in the cells of intralobular and 
larger ducts, b) weak immunoreactivity in the cell luminal 
domain of initial (intercalated) ducts, and c) strong 
immunoreactivity in the luminal domain of acinar cells. In 
many cells we also observed numerous weakly rCfex-
positive intracellular organelles, which suggests that the 
level of the rCfex protein in the apical cell membrane may 
be controlled by vesicle recycling and possibly regulated 
by endo- and exocytosis.
As detected by qRT-PCR, rCfex mRNA in various 
intestinal segments revealed the highest expression was in 
the duodenum, lower in the jejunum, and even lower in the 
ileum, whereas in other segments (stomach, cecum, and 
proximal colon) the expression was negligible. These results 
Table 3 Body mass, urine excretion, and urine biochemical parameters in the sham-operated and gonadectomised male and female rats
Parameter
Males Females
Sham-operated Castrated Sham-operated Ovariectomised
Body mass (g) 289±25 266±29 193±13‡ 232±14§
Urine parameters 
Volume (mL/24 h) 37.6±10.4 25.1±8.9 35.6±12.8 26.2±12.2
Flow (mL/24 h kg bm) 130±33 94±31† 185±68† 113±52‖
Osmolality (mosm kg-1) 267±78 440±188† 266±104 497±373
pH 7.0±0.20 7.3±0.63 6.8±0.59 6.7±0.26
Creatinine, mmol L-1 3.4±4.17 3.5±1.68 2.4±2.44 3.9±3.19
µmol/24 h kg bm 244±34 293±42† 259±41 306±47‖
Calcium, mmol L-1 0.46±0.20 0.76±0.29† 1.31 ±0.82† 1.24±0.86
mmol/24 h kg bm 3.8±1.76 9.4±5.90† 8.5±7.14 23.7±34.09
Citrate, mmol L-1 1.15±0.34 2.15±1.36† 1.45±0.53 2.11±1.23
µmol/24 h kg bm 142±34 176±46 241±47‡ 186±81
mmol/mol creatinine 593±168 597±118 949±239† 593±202‖
Oxalate, µmol L-1 182±90 256±135 203±167 219±105
µmol/24 h kg bm 20.3±5.1 20.7±4.1 19.0±7.1 20.1±5.6
mmol/mol creatinine 83±14.1 71±11.7 73±29.6 65±14.8
The results are presented as means ±SD of body mass and biochemical parameters in 24-h urine collected from 9 to 10 animals in 
each experimental group. †P=0.001-0.047 vs. sham-operated males; ‡P<0.001 vs. sham-operated males; §P<0.001 vs. sham-operated 
females; ‖P=0.001-0.030 vs. sham-operated females. Other comparisons were not statistically significant (P>0.05)
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Figure 7 Immunolocalisation of the rCfex protein in the kidneys of prepubertal male and female rats; comparison with adult animals.
A Western blots of total cell membranes (80 µg protein/lane), isolated from the whole kidneys from 4 male and 4 female prepubertal 
rats, and from one adult male (AM) and female (AF) rat, blotted with CFEX-Ab and actin-Ab. B Densitometric evaluation of the protein 
bands shown in A. Data for adult rats are from a single animal, whereas the data for prepubertal animals are means ±SD (n=4 in each 
group). Statistics for the rCfex and actin data in prepubertal rats: Males vs. Females, N.S. (P>0.05). C Representative (out of 3 similar) 
rCfex-Ab-related immunostaining in the kidney cortex (CO) and outer stripe (OS) in adult and prepubertal male and female rats. Bar 
(for all images), 20 µm
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differ from the Northern hybridisation data in mouse 
intestine, showing this sequence of expression: 
duodenum=jejunum > ileum > proximal colon > cecum > 
distal colon (17, 18). Our immunochemical data of the 
intestinal rCfex matched the mRNA expression, showing 
the rCfex protein in the BBM of duodenal and jejunal 
enterocytes (duodenum > jejunum). In other segments, 
including the stomach, the rCfex protein could not been 
visualised. In the mouse stomach, the mCfex protein was 
previously detected with a different antibody and found 
colocalised with gastric H+-K+-ATPase in parietal cells (22). 
This suggests that intestinal Cfex mRNA and protein 
expression implies species differences between rats and 
mice.
The role of Cfex in the murine small intestine has been 
functionally defined in studies on wild type and mCfex 
knockout mice, in Cfex-transfected cell lines and in Xenopus 
oocytes (5, 7, 18, 26, 28, 29, 31). Two of them also described 
species differences in kinetic properties between the mouse 
and human Cfex/CFEX proteins. The mCfex-mediated Cl-/
oxalate2- exchange was electrogenic with high affinity for 
Cl-, whereas the human exchanger was electroneutral (2Cl-/
oxalate2-), with low affinity for Cl- (5, 50). Previously 
published data indicates that duodenal and ileal Cfex could 
mediate absorption of luminal Cl- or SO4
2- in exchange for 
secreted HCO3
- or oxalate (7, 26, 28, 29). With the latter 
function, the exchanger should significantly contribute in 
eliminating oxalate from the body (26, 34), thus preventing 
the development of hyperoxalemia, which can lead to 
subsequent hyperoxaluria and Ca-oxalate nephrolithiasis, 
as has been demonstrated in the mCfex knockout mouse 
model (32, 34, 51).
The segment-related expression of Cfex protein along 
the renal proximal tubule (S1/S2 in the cortex << S3 in 
medullary rays and outer stripe) and sex differences in the 
expression of Cfex mRNA and protein (males > females) 
found in our study in rats have not been previously reported 
for other species. In a study using northern hybridisation 
(10), rCfex/PAT-1 mRNA was highly expressed in the 
kidney cortex and weakly in the outer and inner medulla, 
whereas immunocytochemical staining localised the rCfex 
protein in the proximal tubule BBM. The mCfex protein 
was also stained in the BBM of the proximal tubules (11, 
16), but in humans, CFEX was detected in the distal 
segments of the proximal tubules and in several more distal 
nephron parts (12), which all points to species differences 
in the nephron localisation of this transporter between 
rodents and humans. In various transport studies, performed 
in microperfused proximal tubules from wild type and 
mCfex knockout mice (10, 11, 25, 29), isolated BBM (10, 
11, 25, 52), and mCfex- and CFEX-transfected Xenopus 
oocytes (5, 50), the renal Cfex/CFEX was shown to function 
predominantly as Cl-/HCO3
- or Cl-/oxalate exchanger, thus 
serving in reabsorption of Cl- and secretion of HCO3
- and 
oxalate. As shown in the mouse kidney, a strongly 
diminished transport of oxalate in renal BBM vesicles 
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isolated from mCfex-knockout animals, and much higher 
affinity of renal mCfex for oxalate than for HCO3
- (25, 52) 
indicate Cl-/oxalate exchange as the primary role of the 
renal transporter.
Two phenomena related to our findings of male-
dominant testosterone-induced rCfex protein expression in 
the kidney deserve particular attention. One is the segment-
dependent abundance of rCfex, which is in S3 much higher 
than in S1/S2. Previous studies assumed that oxalate 
elimination via proximal tubule cells was mediated by the 
concerted action of the basolateral Sat-1, which pumps 
SO4
2- out and oxalate into the cell, and luminal Cfex, which 
transports oxalate into the tubule lumen in exchange for 
Cl- [reviewed in (1, 2, 35)]. In the rat kidney, this pattern 
may be valid for S1/S2 segments, which exhibit male-
dominant expression of both rSat-1 (37, 40) and rCfex (this 
study), but is not entirely true for the S3 segments, where 
apical rCfex expression is higher (this study) and basolateral 
rSat-1 lower (37, 53). It remains for the future studies to 
resolve the physiological role of the male-dominant rCfex 
expression in the S3 segment in secretion or reabsorption 
of oxalate and other related anions.
The other phenomenon are strong male-dominant sex 
differences in rCfex expression along the entire proximal 
tubule, which may be relevant to the well-known male-
dominant prevalence of urolithiasis in humans and animals 
[reviewed in (1, 2, 35)]. According to the urine parameters 
in Table 3, similar urine concentrations and 24-h excretion 
of oxalate in the sham-operated and gonadectomised male 
and female rats suggests no apparent relation between 
oxalate excretion and renal rCfex expression, which is in 
contradiction with some previously reported studies (26, 
29, 34).
Male-dominant expression of renal rCfex in our study 
may play a role in hyperoxalaemic conditions such as 
chronic renal failure (54, 55), inflammatory bowel disease, 
small bowel resection (28), and urolithiasis induced by 
ethylene glycol (EG) in rats (40). Several studies have 
shown that male rats have a predilection toward kidney 
stones and that testosterone enhances while oestrogen 
inhibits urinary stone formation in normal and EG-treated 
animals (56–58), but the expression and the role of Cfex 
was not investigated in those studies. However, higher 
excretion of citrate in healthy females than males [(40) and 
this study] may point to a major protective mechanism 
against the formation of Ca-oxalate crystals. An in vitro 
study by Ohana et al. (32) showed that mCfex can interact 
with and inhibit the activity of sodium-dicarboxylate 
cotransporter mNaDC-1/Slc13a2 located in the proximal 
tubule BBM, which reabsorbs filtrated citrate. In vivo, such 
inhibition could result in citrate retention in the tubular 
fluid, which would bind Ca2+ and ensure safe oxalate 
elimination through urine (32). The 24-h urine in our 
previous (40) and present study consistently showed 
significant sex differences (males<females) in the excreted 
citrate but not oxalate. These differences disappeared with 
ovariectomy (this study), suggesting that in rats, female sex 
hormones regulate (stimulate) citrate excretion by 
modulating the activity and/or expression of NaDC-1, while 
the Cfex remains unaffected. EG-induced urolithiasis, 
hyperoxaluria, and hypocitraturia in rats (40) generated 
conditions for the formation of Ca-oxalate crystals in male 
but not female animals. Since male rats exhibit higher renal 
expression of the rCfex protein than females (this study), 
it is possible that this and several other conditions with 
hyperoxaluria and Ca-oxalate urolithiasis may involve an 
interaction between Cfex and NaDC-1, such as inflammatory 
bowel disease and conditions resulting from small bowel 
resection (28, 35).
Earlier Northern blotting and/or RT-PCR studies have 
detected CFEX/Cfex mRNA in the liver of humans (13–15) 
and mice (16), but no CFEX/Cfex protein has been localised 
to hepatocytes in these species so far. Following up on our 
preliminary report in the rat liver of a few years ago (2), 
we have now confirmed its exclusive presence in the bile 
canaliculi, where it may play a role in elimination of oxalate 
from hepatocytes into bile. Judging by the CFEX-Ab-related 
immunostaining intensity its expression was sex-
independent. Liver is the organ with the largest capacity of 
producing oxalate from various precursors [reviewed in (2, 
35)]. This is particularly clear in hepatectomised rats, whose 
production of oxalate from the precursor glycolate dropped 
more than 80 % (59). Being an end-product of metabolism 
and toxic for the cell, most of oxalate is removed from the 
hepatocytes via Sat-1-mediated SO4
2-/oxalate exchange 
located in the sinusoidal membrane [reviewed in (1, 2, 35)]. 
In an experimental rat model of EG-induced hyperoxaluria, 
the expression of rSat-1 mRNA and rSat-1 protein in the 
liver (and kidneys) exhibited only limited changes (39, 40), 
whereas in Sat-1 knockout mice with hyperoxalaemia, 
hyperoxaluria, and nephrolithiasis (33) the mode of oxalate 
elimination from hepatocytes has not been explained. 
Previous transport studies by Meier et al. (60) in canalicular 
plasma membrane vesicles isolated from the rat liver 





2-/oxalate exchange. According to Boyer (61), HCO3
- is 
secreted into the bile in exchange for Cl- by anion exchanger 
2 (AE2/SLC4A2) located in the bile canalicular membrane, 
and the out-to-in gradient of bicarbonate may drive SO4
2- 
and oxalate exit by another exchanger in the same 
membrane, possibly Cfex. We therefore propose that oxalate 
produced in the liver can leave the hepatocyte via sinusoidal 
Sat-1 (2, 37) and canalicular Cfex. The Cfex-mediated 
excretion of oxalate may be low under physiological 
conditions and may increase in case of impaired oxalate 
clearance, as shown in rats with kidney failure (54). For 
example, in nephrectomised rats, biliary secretion of oxalate 
was reported to account for ~18 % of the total clearance 
(62). Future experiments will need to identify changes in 
hepatic Cfex expression and its role in hyperoxalaemia and 
hyperoxaluria.
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Figure 8 Effect of gonadectomy on the rCfex protein expression in male kidneys. A Western blots of the whole kidney total cell 
membranes, isolated from 4 sham-operated and 4 castrated animals, with CFEX-Ab and actin-Ab. Each lane contained 80 µg protein.
B Densitometric evaluation of the protein bands shown in A. Shown are means ±SD (n=4 in each bar). *vs. rCfex in sham-operated 
males, P<0.002. The actin band had similar density in the membranes from both groups (P>0.05). C rCfex-Ab-related immunostaining 
in the cortical (CO) and outer stripe (OS) proximal tubule segments (S1/S2 and S3) from sham-operated and castrated animals. G, 
glomeruli. Bar (for all images), 20 µm. Data are representative for 3 animals in each group. D Staining intensity in the brush-border 
membrane of cortical (CO, S1/S2) and outer stripe (OS, S3) proximal tubule segments. Shown are relative fluorescence intensities 
(means ±SD; n=3 in each bar). Statistics: In CO, a vs. c, N.S. (P>0.05); In OS, b vs. d, P<0.005
Figure 9 Effect of sex hormone treatment in castrated rats on renal rCfex protein expression. A Western blots (representative for 2 
different sets of membrane preparations) of total cell membranes, isolated from the outer stripe of sham-operated and castrated rats 
treated with sunflower oil or sex hormones (Test, testosterone; Estr, oestrogen; Prog, progesterone) for two weeks, with CFEX-Ab and 
actin-Ab. Each lane contained 80 µg protein. B Densitometric evaluation of the bands shown in A. Shown are means ±SD of the data 
collected from two independent experiments (n=4 in each group); Statistics: a vs. b, d or e; b vs. c, and c vs. d or e, P<0.001; Other 
relationships, N.S. (P>0.05). The actin protein band was not changed by the treatments (A). C The CFEX-Ab-related immunostaining 
in cortical (CO) and outer stripe (OS) proximal tubule segments. Images are representative for similar findings in 3 animals in each 
group. Bar (for all images), 20 µm
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In conclusion, by applying the commercial polyclonal 
anti-CFEX antibody (sc-26728) in rat tissues, the putative 
rCfex protein was detected in a few known localizations 
(duodenal and jejunal BBM, luminal domain of pancreatic 
intercalated ducts, BBM in proximal tubules), and a few 
previously unknown localizations (bile canalicular 
membrane in hepatocytes, and apical membrane and 
intracellular organelles in pancreatic acinar cells). The 
expression of rCfex was found sex-dependent only in 
kidneys, exhibiting a strong male-dominant expression 
driven by androgen stimulation after the puberty. The 
described localizations may be important in handling 
oxalate and related anions in physiological and 
pathophysiological conditions. However, while the applied 
antibody worked well by immunocytochemistry in tissue 
cryosection, by immunoblotting it labelled no protein in the 
membranes isolated from transfected cells, but labelled the 
protein band of ~120 kDa in the membranes isolated from 
various organs. In our preliminary studies, we have also 
tested the two other commercially-available anti-Cfex 
antibodies, one polyclonal (sc-26735) and one monoclonal 
(sc-515230), which are supposed to label Cfex in rodents; 
both were ineffective in our immunochemical experiments, 
and thus, we could not prove with an independent approach 
if the ~120 kDa protein was strictly related to rCfex. Yet, 
the CFEX-Ab-related density pattern of ~120 kDa protein 
fully matched the pattern of immunostaining in various 
tissues, indicating the possibility that both, the protein band 
and immunostaining reflect the same protein expression.
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bm – body mass; BBM – brush border membrane; BCP – 
5-bromo-4-chloro-3-indolyl-phosphate; cDNA – 
complementary deoxyribonucleic acid; CFEX (Cfex)/
Figure 10 Immunolocalisation and sex-independent expression of the rCfex protein in the liver. A CFEX-Ab-related immunoreactivity 
in hepatocytes. The immunostaining with CFEX-Ab (-P) and with the immunising peptide-blocked antibody (+P). The colour figure 
(and insert) shows a representative, double-stained cryosection with CFEX-Ab (red fluorescence) and Na+/K+-ATPase-Ab (green 
fluorescence). Arrows, rCfex in bile canaliculi; arrowheads, Na+/K+-ATPase in sinusoidal membrane; CV, central vein; PV, portal 
vein. B Western blot of total cell membranes (TCM) from the liver tissue with CFEX-Ab (-P) and with the same, immunising peptide-
blocked antibody (+P). C Western blots of TCM with CFEX-Ab and actin-Ab. Each lane contained 80 µg protein of different membrane 
preparations. D Densitometric evaluation of the bands shown in B. Shown are means ±SD (n=4 in each group). Statistics: Males vs. 
Females (rCfex or actin), N.S. (P>0.05). E The CFEX-Ab-related immunostaining in male and female livers, representing similar 
findings in tissue cryosections from 3 rats of each sex. Bars (for all images in the respective panel), 20 µm
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SLC26A6 (Slc26a6) – chloride-formate exchanger/member 
A6 of the solute carrier family 26; CFEX-Ab – chloride-
formate exchanger antibody; DAG-CY3 – cyanine 
3-labelled donkey anti-goat IgG; EG – ethylene glycol; 
GAM-AP – goat anti-mouse IgG; GAM-FITC – fluorescein 
isothiocyanate-labelled goat anti-mouse IgG; HEK293 – 
human embrionic kidney cell line 293; NaDC-1/Slc13a2 
– sodium dicarboxylate cotransporter 1/member a2 of the 
solute carrier family 13; Mr – relative molecular mass; Na+/
K+-ATPase – sodium-potassium adenosine triphosphatase; 
NBT – nitro blue tetrazolium; PAT-1 – putative anion 
transporter 1; PBS – phosphate buffer solution; PEI – 
polyethyleneimine; PFA – p-formaldehyde; RAG-AP – 
alkaline phosphatase-labelled rabbit anti-goat IgG; Hprt1 
– hypoxanthine phosphoribosyltransferase 1 housekeeping 
gene; ROI – regions of interest; β-actin – beta actin 
housekeeping gene; S1-3 – segments 1, 2, and 3 of the 
kidney proximal tubule; Sat-1/Slc26a1 – sulphate anion 
transporter; SDS-PAGE – sodium dodecyl sulphate 
polyacrylamide gel electrophoresis; TCM – total cell 
membranes
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Spolno-neovisna ekspresija izmjenjivača klora i mravlje kiseline Cfex (Slc26a6) u gušterači, tankom crijevu i 
jetri štakora i povišena ekspresija u bubrezima mužjaka
Izmjenjivač klora i mravlje kiseline (CFEX; SLC26A6) posreduje prijenos oksalata u različitim organima sisavaca. Pokusi 
u miševa s isključenim genom Cfex upućuju na moguću ulogu toga prijenosnika u razvoju hiperoksalurije i oksalatne 
urolitijaze, češćih u muških osoba. Štakori su važan model za istraživanje toga patofiziološkoga stanja, ali su spoznaje o 
lokalizaciji i regulaciji Cfex-a (rCfex) u njihovim organima nedostatne. U ovom radu primijenili smo metode RT-PCR i 
imunokemije u svrhu istraživanja ekspresije rCfex mRNA i proteina te regulacije istih spolnim hormonima u gušterači, 
tankom crijevu, jetri i bubrezima u različito tretiranih odraslih i predpubertetskih štakora obaju spolova. rCfex cDNA-
transficirane stanice HEK293 uporabljene su za potvrdu specifičnosti komercijalnoga protutijela. Različiti biokemijski 
parametri izmjereni su u 24-satnom urinu, prikupljenom u metaboličkim kavezima. Ekspresija rCfex mRNA i proteina 
bila je prisutna u svim ispitanim organima. O spolu neovisna ekspresija prijenosnika rCfex nađena je u apikalnoj domeni 
interkaliranih kanalića gušterače, četkastoj membrani enterocita u tankom crijevu (duodenum > jejunum > ileum) i 
kanalikularnoj membrani hepatocita. U bubrezima je a) prijenosnik rCfex imunolokaliziran u četkastoj membrani 
proksimalnih kanalića sa segment-specifičnim obrascem (S1=S2<S3) i b) ekspresija rCfex mRNA i proteina iskazala je 
spolne razlike (mužjaci > ženke) zbog stimulacijskoga učinka androgena nakon puberteta. Međutim, izlučivanje oksalata 
urinom nije bilo sukladno ekspresiji bubrežnoga prijenosnika rCfex. Dakle, nejasan je učinak povišene ekspresije 
prijenosnika rCfex u proksimalnim kanalićima mužjaka na izlučivanje oksalata, a postojanje prijenosnika u kanalikularnoj 
membrani hepatocita mogući je put izlučivanja oksalata putem žuči.
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urolitijaza
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